Long-term prognosis of chronic total occlusion treated by successful percutaneous coronary intervention in patients with or without diabetes mellitus: a systematic review and meta-analysis

Table 5 Baseline characteristics of non-DM patients treated by successful-CTO PCI versus CTO-MT

Study	Age (yrs) PCI/MT	Male (%) PCI/MT	Smoker(%) PCI/MT	HTN (%) PCI/MT	LVEF(%) PCI/MT	CTO location (%) LAD/LCX/RCA	MVD (%) PCI/MT	J-CTO PCI/MT	SYNTAX PCI/MT
Claessen et al	60.9 ± 11.0/ 62.1 ± 10.7	85.9/89.8	25.8/21.8	57.2/55.1	54.3 ± 10.1/ 53.0 ± 10.5	PCI:37.7/21.9/39.9 MT:30.4/22.2/46.9	64.6/74.0	NA/NA	NA/NA
Guo et al	62.9 ± 10.1/ 64.3 ± 11.0	79.1/82.2	46.7/46.0	62.9/64.2	54.8 ± 8.1 52.3 ± 9.6	PCI:40.5/22.4/48.0 MT:33.1/30.7/47.9	63.5/86.3	1.47 ± 1.03/ 1.80 ± 1.24	18.9 ± 6.9/ 22.6 ± 8.8
Tsai et al	66 ± 14/ 68 ± 13	96/90	46/42	68/75	50 ± 12/ 48 ± 14	PCI:46/26/44 MT:42/29/46	78/83	2.31 ± 0.99/ 2.40 ± 0.89	19 ± 6/ 20 ± 7
Sanguineti et al	62.2 ± 11.6	86.7	28.6	54.0	57.1 ± 9.57	31.1/21.6/47.2/0.1	59.4	1.34 ± 0.9	NA

DM diabetes mellitus, CTO chronic total occlusion, PCI percutaneous coronary intervention, MT medical treatment, HTN hypertension, LVEF left ventricular ejection fraction, LAD left anterior descending artery, LCX left circumflex artery, RCA right coronary artery, MVD multivessel disease, J-CTO Japanese-chronic total occlusion, NA not available

ISSN: 1475-2840